Marcin Osuch

ORCID: 0000-0003-4615-0189
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal and Vascular Pathologies
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Peripheral Artery Disease Management
  • MRI in cancer diagnosis
  • Cardiac Structural Anomalies and Repair
  • Cardiac Imaging and Diagnostics
  • Transplantation: Methods and Outcomes
  • Steroid Chemistry and Biochemistry
  • Cardiac Valve Diseases and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Cloud Computing and Resource Management
  • Viral Infections and Immunology Research
  • Mechanical Circulatory Support Devices
  • Metabolomics and Mass Spectrometry Studies
  • SARS-CoV-2 and COVID-19 Research
  • Growth Hormone and Insulin-like Growth Factors
  • Advanced Data Storage Technologies
  • Aortic aneurysm repair treatments
  • Receptor Mechanisms and Signaling
  • Nursing Roles and Practices
  • Cardiac Fibrosis and Remodeling
  • Chemical Reactions and Isotopes
  • COVID-19 epidemiological studies

Institute of Bioorganic Chemistry, Polish Academy of Sciences
2021-2024

Scanmed (Poland)
2016-2020

Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu
2017

Górnośląskie Centrum Medyczne
2016

Medical University of Silesia
2009-2014

Silesian Center for Heart Disease
2007-2008

Mater Mothers' Hospital
2001

Northwestern University
1969

Chronic kidney disease (CKD) is characterized by the progressive loss of functional nephrons. Although cardiovascular (CVD) complications and atherosclerosis are leading causes morbidity mortality in CKD, mechanism which progression CVD accelerates remains unclear. To reveal molecular mechanisms associated with linked to we applied a shotgun lipidomics approach fortified standard laboratory analytical methods gas chromatography-mass spectrometry technique on selected lipid components...

10.3390/metabo11050275 article EN cc-by Metabolites 2021-04-27

<i>Background/Aim:</i> Scarce data exist concerning the long-term effect of renal balloon angioplasty (PTRA) enhanced by intravascular γ-brachytherapy (IVBT) in patients with renovascular hypertension. The aim this randomized study was to evaluate outcome after PTRA IVBT artery stenosis. <i>Patients and Methods:</i> 71 hypertension were into group I (PTRA + IVBT) or II (PTRA). 9 who required stent implantation excluded. Both baseline 9-month follow-up quantitative...

10.1159/000153249 article EN Kidney & Blood Pressure Research 2008-01-01

The biodegradable polymer drug-eluting stents were developed to improve vascular healing. However, further data are needed confirm the safety and efficacy of these in patients with acute myocardial infarction (AMI).We sought determine 1-year clinical follow-up AMI treated a thin strut polymer-coated sirolimus-eluting stent (BP-SES) versus durable coating everolimus-eluting (DP-EES).We analyzed (STEMI NSTEMI) either BP-SES (ALEX, Balton, Poland, n = 886) or DP-EES (XIENCE, Abbott, USA, 1054)...

10.5114/aic.2018.79194 article EN cc-by-nc-sa Advances in Interventional Cardiology 2018-01-01

The largest group of patients with secondary hypertension comprises individuals renovascular resulting from renal artery stenosis that is a potentially removable condition. It caused by atherosclerosis in 70-80% patients.The aim the study was to evaluate influence intravascular brachytherapy (IVBT) procedure performed after percutaneous transluminal angioplasty (PTRA) on left ventricular (LV) function, mass regression and type hypertrophy (LVH) determined echocardiography during long-term...

10.20452/pamw.656 article EN Polskie Archiwum Medycyny Wewnętrznej 2009-04-01

Abstract Objectives We sought to determine the 1‐year clinical follow‐up in patients treated with thin strut (71 μm) bioabsorbable polymer‐coated sirolimus‐eluting stent (BP‐SES) vs durable coating everolimus eluting (DP‐EES) daily routine. Background Presence of polymers may be associated late/very late thrombosis occurrence and need for prolonged dual antiplatelet therapy. Bioabsorbable facilitate healing, thus enhancing safety. Methods Interventional Cardiology Network Registry is a...

10.1002/ccd.27919 article EN Catheterization and Cardiovascular Interventions 2018-10-08

Background: The number of patients with diabetes mellitus (DM) presenting coronary artery disease is increasing and accounts for more than 30% undergoing percutaneous interventions (PCI). biodegradable polymer drug-eluting stents were developed to improve vascular healing. It was sought herein, determine 1-year clinical follow-up in DM treated the thin strut polymer-coated sirolimus-eluting stent (BP-SES) versus durable coating everolimus-eluting (DP-EES). Methods: Patients retrospectively...

10.5603/cj.a2019.0111 article EN cc-by-nc-nd Cardiology Journal 2020-01-07

Abstract The COVID-19 pandemic has profoundly affected all aspects of our lives. Through real-time monitoring and rapid vaccine implementation, we succeeded in suppressing the spread disease mitigating its consequences. Finally, conclusions can be summarized drawn. Here, use example Poland, which was seriously by pandemic. Compared to other countries, Poland not achieved impressive results either testing or vaccination, may explain high mortality (case fatality rate, CFR 1.94%)....

10.1038/s41598-024-65468-5 article EN cc-by Scientific Reports 2024-06-22

10.1016/0006-2952(69)90274-3 article EN Biochemical Pharmacology 1969-08-01
Coming Soon ...